共 50 条
- [41] Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma BJUI COMPASS, 2021, 2 (05): : 322 - 330
- [45] ONCOLOGICAL OUTCOMES IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA AFTER DISCONTINUING PEMBROLIZUMAB AS A SECOND-LINE TREATMENT: A RETROSPECTIVE MULTICENTER REAL-WORLD COHORT STUDY JOURNAL OF UROLOGY, 2023, 209 : E439 - E439
- [49] IMPACT OF STATIN USE ON ONCOLOGICAL OUTCOMES OF PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY JOURNAL OF UROLOGY, 2013, 189 (04): : E584 - E585
- [50] Variant Histology: The Impact on Oncological Outcomes of Patients with Urothelial Carcinoma of The Bladder Treated with Radical Cystectomy JOURNAL OF UROLOGICAL SURGERY, 2021, 8 (04): : 243 - 247